17.06
0.71 (4.34%)
Market Trend
Short Term | Medium Term | ||
Industry | Health Information Services (US) | Bearish | Bearish |
Health Information Services (Global) | Bearish | Bearish | |
Stock | Certara, Inc. | Bullish | Bearish |
Analyst Consensus
1 Buy, 3 Hold
Avg. Price @ Call: 17.98
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region. |
|
Sector | Healthcare |
Industry | Health Information Services |
Investment Style | Small Growth |
52 Weeks Range |
11.81 - 22.65
|
|
Price Target Range | ||
High | 23.00 (Keybanc, 34.82%) | Buy |
Median | 19.50 (14.30%) | |
Low | 15.50 (Jefferies, -9.14%) | Hold |
Average | 19.38 (13.57%) | |
Total | 1 Buy, 3 Hold |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Keybanc | 10 Apr 2024 | 23.00 (34.82%) | Buy | 18.46 |
Jefferies | 01 Mar 2024 | 15.50 (-9.14%) | Hold | 18.30 |
UBS | 01 Mar 2024 | 20.00 (17.23%) | Hold | 18.30 |
Leerink Partners | 26 Feb 2024 | 19.00 (11.37%) | Hold | 16.86 |
No data within this time range.
Date | Type | Details |
---|---|---|
07 May 2024 | Announcement | Certara Reports First Quarter 2024 Financial Results |
16 Apr 2024 | Announcement | Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform |
09 Apr 2024 | Announcement | Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference |
29 Feb 2024 | Announcement | Certara Reports Fourth Quarter 2023 Financial Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2024 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |